SEARCH GO
Cancer Information | Patient Information | Research | How You Can Help | About Us
HOME : SITE MAP : HELP : CONTACT US : MEDIA : MISSION
Lessnick Lab
Research Overview
Publications
Lab Members
Links
Supplemental Data
Public Data Gangwal K and Lessnick SL. Microsatellites are EWS/FLI response elements: Genomic "junk" is EWS/FLI's treasure. Cell Cycle 2008 Oct 15; 7(20), 3127 - 3132 • Publication Reprint (PDF) Gangwal K, Sankar S, Hollenhorst PC, Kinsey M, Haroldsen SC, Shah AA, Boucher KM, Watkins WS, Jorde LB, Graves BJ, Lessnick SL. Microsatellites as EWS/FLI response elements in Ewing's sarcoma. Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10149-54. • Supplemental data Owen LA, Kowalewski AA, and Lessnick SL. EWS/FLI mediates transcriptional repression via NKX2.2 during oncogenic transformation in Ewing's sarcoma. PLoS ONE. 2008 April; 3(4): 1965. • Supplemental data Hancock JD and Lessnick SL. A transcriptional profiling meta-analysis reveals a core EWS-FLI gene expression signature. Cell Cycle 2008. January 15; 7(2):250-256." • Supplemental data Braunreiter CL, Hancock JD, Coffin CM, Boucher KM, Lessnick SL. Expression of EWS-ETS fusions in NIH3T3 cells reveals significant differences to Ewing's sarcoma. Cell Cycle. 2006 Dec;5(23):2753-9 • Supplemental data Kinsey, M., Smith, R., and Lessnick, S.L. (2006) NR0B1 Is Required for the Oncogenic Phenotype Mediated by EWS/FLI in Ewing's Sarcoma. Mol Cancer Res 4, 851-859 • Supplemental data Owen LA, Lessnick SL. Identification of target genes in their native cellular context: an analysis of EWS/FLI in Ewing's sarcoma. Cell Cycle. 2006 Sep;5(18):2049-53 • Publication Reprint (PDF) Smith R, Owen LA, Trem DJ, Wong JS, Whangbo JS, Golub TR, Lessnick SL. Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma. Cancer Cell. 2006 May;9(5):405-16 • Supplemental data McAllister NR, Lessnick SL. The potential for molecular therapeutic targets in Ewing's sarcoma. Curr Treat Options Oncol. 2005 Nov;6(6):461-71 • Publication Reprint (PDF) Randall RL, Lessnick SL, Johnson B, Joyner DE. The potential for molecular therapeutic targets in Ewing's sarcoma. Current Op in Ortho. 2004 Dec;15(6):456-467 • Publication Reprint (PDF) Lessnick SL, Dacwag CS, Golub TR. The Ewing's sarcoma oncoprotein EWS/FLI induces a p53-dependent growth arrest in primary human fibroblasts. Cancer Cell. 2002 May;1(4):393-401 • Supplemental data Secured Data
Gangwal K and Lessnick SL. Microsatellites are EWS/FLI response elements: Genomic "junk" is EWS/FLI's treasure. Cell Cycle 2008 Oct 15; 7(20), 3127 - 3132 • Publication Reprint (PDF) Gangwal K, Sankar S, Hollenhorst PC, Kinsey M, Haroldsen SC, Shah AA, Boucher KM, Watkins WS, Jorde LB, Graves BJ, Lessnick SL. Microsatellites as EWS/FLI response elements in Ewing's sarcoma. Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10149-54. • Supplemental data Owen LA, Kowalewski AA, and Lessnick SL. EWS/FLI mediates transcriptional repression via NKX2.2 during oncogenic transformation in Ewing's sarcoma. PLoS ONE. 2008 April; 3(4): 1965. • Supplemental data Hancock JD and Lessnick SL. A transcriptional profiling meta-analysis reveals a core EWS-FLI gene expression signature. Cell Cycle 2008. January 15; 7(2):250-256." • Supplemental data
Gangwal K and Lessnick SL. Microsatellites are EWS/FLI response elements: Genomic "junk" is EWS/FLI's treasure. Cell Cycle 2008 Oct 15; 7(20), 3127 - 3132
• Publication Reprint (PDF)
Gangwal K, Sankar S, Hollenhorst PC, Kinsey M, Haroldsen SC, Shah AA, Boucher KM, Watkins WS, Jorde LB, Graves BJ, Lessnick SL. Microsatellites as EWS/FLI response elements in Ewing's sarcoma. Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10149-54.
• Supplemental data
Owen LA, Kowalewski AA, and Lessnick SL. EWS/FLI mediates transcriptional repression via NKX2.2 during oncogenic transformation in Ewing's sarcoma. PLoS ONE. 2008 April; 3(4): 1965.
Hancock JD and Lessnick SL. A transcriptional profiling meta-analysis reveals a core EWS-FLI gene expression signature. Cell Cycle 2008. January 15; 7(2):250-256."
Braunreiter CL, Hancock JD, Coffin CM, Boucher KM, Lessnick SL. Expression of EWS-ETS fusions in NIH3T3 cells reveals significant differences to Ewing's sarcoma. Cell Cycle. 2006 Dec;5(23):2753-9 • Supplemental data
Kinsey, M., Smith, R., and Lessnick, S.L. (2006) NR0B1 Is Required for the Oncogenic Phenotype Mediated by EWS/FLI in Ewing's Sarcoma. Mol Cancer Res 4, 851-859 • Supplemental data
Owen LA, Lessnick SL. Identification of target genes in their native cellular context: an analysis of EWS/FLI in Ewing's sarcoma. Cell Cycle. 2006 Sep;5(18):2049-53 • Publication Reprint (PDF)
Smith R, Owen LA, Trem DJ, Wong JS, Whangbo JS, Golub TR, Lessnick SL. Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma. Cancer Cell. 2006 May;9(5):405-16 • Supplemental data
McAllister NR, Lessnick SL. The potential for molecular therapeutic targets in Ewing's sarcoma. Curr Treat Options Oncol. 2005 Nov;6(6):461-71 • Publication Reprint (PDF)
Randall RL, Lessnick SL, Johnson B, Joyner DE. The potential for molecular therapeutic targets in Ewing's sarcoma. Current Op in Ortho. 2004 Dec;15(6):456-467 • Publication Reprint (PDF)
Lessnick SL, Dacwag CS, Golub TR. The Ewing's sarcoma oncoprotein EWS/FLI induces a p53-dependent growth arrest in primary human fibroblasts. Cancer Cell. 2002 May;1(4):393-401 • Supplemental data
Last Modified: Wednesday, December 31, 1969
HOME : SITE MAP : HELP : CONTACT US : DISCLOSURE : PRIVACY STATEMENT Huntsman Cancer Institute operates a hospital-based patient care center in association with the Health Sciences Center at the University of Utah. University of Utah disclaimer. Copyright © 2008, all rights reserved, Huntsman Cancer Institute.
